New anti-tuberculosis drugs in clinical trials with novel mechanisms of action
EC Rivers, RL Mancera - Drug Discovery Today, 2008 - Elsevier
Tuberculosis is a major health problem worldwide, with approximately 1.7 million people
dying annually from the disease. The long current drug regimen, the emergence of drug …
dying annually from the disease. The long current drug regimen, the emergence of drug …
New anti-tuberculosis drugs in clinical trials with novel mechanisms of action
EC Rivers, RL Mancera - Drug discovery today, 2008 - pubmed.ncbi.nlm.nih.gov
Tuberculosis is a major health problem worldwide, with approximately 1.7 million people
dying annually from the disease. The long current drug regimen, the emergence of drug …
dying annually from the disease. The long current drug regimen, the emergence of drug …
New anti-tuberculosis drugs in clinical trials with novel mechanisms of action
EC Rivers, RL Mancera - Drug Discovery Today, 2008 - infona.pl
Tuberculosis is a major health problem worldwide, with approximately 1.7 million people
dying annually from the disease. The long current drug regimen, the emergence of drug …
dying annually from the disease. The long current drug regimen, the emergence of drug …
New anti-tuberculosis drugs in clinical trials with novel mechanisms of action.
EC Rivers, RL Mancera - Drug Discovery Today, 2008 - europepmc.org
Tuberculosis is a major health problem worldwide, with approximately 1.7 million people
dying annually from the disease. The long current drug regimen, the emergence of drug …
dying annually from the disease. The long current drug regimen, the emergence of drug …
New anti-tuberculosis drugs in clinical trials with novel mechanisms of action
E Rivers, R Mancera - Drug Discovery Today, 2008 - espace.curtin.edu.au
Tuberculosis is a major health problem worldwide, with approximately 1.7 million people
dying annually from the disease. The long current drug regimen, the emergence of drug …
dying annually from the disease. The long current drug regimen, the emergence of drug …
[引用][C] New anti-tuberculosis drugs in clinical trials with novel mechanisms of action
EC RIVERS, RL MANCERA - Drug discovery today, 2008 - pascal-francis.inist.fr
New anti-tuberculosis drugs in clinical trials with novel mechanisms of action CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
[PDF][PDF] New anti-tuberculosis drugs in clinical trials with novel mechanisms of action
EC Rivers, RL Mancera - Drug Discovery Today, 2008 - academia.edu
Tuberculosis is a major health problem worldwide, with approximately 1.7 million people
dying annually from the disease. The long current drug regimen, the emergence of drug …
dying annually from the disease. The long current drug regimen, the emergence of drug …